View ValuationAtlas Arteria 향후 성장Future 기준 점검 3/6Atlas Arteria (는) 각각 연간 20.5% 및 4.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 15.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 7% 로 예상됩니다.핵심 정보20.5%이익 성장률15.13%EPS 성장률Infrastructure 이익 성장5.8%매출 성장률4.8%향후 자기자본이익률7.04%애널리스트 커버리지Good마지막 업데이트23 Jul 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공고 • Jul 08+ 1 more updateAtlas Arteria Limited Announces Board and Committee ChangesAtlas Arteria refers to the off-market takeover offer by Diamond Infraco 1 Pty Ltd. The IFM Takeover Offer closed on 7 July 2026. As previously announced, Debbie Goodin has retired as the Independent Non-executive Chair of Atlas Arteria Limited (ATLAX). This took effect a er the close of the IFM Takeover Offer on 7 July 2026. Current Independent Non-executive ATLAX Director John Wigglesworth has been appointed Interim Chair of ATLAX. As a result, Mr. Wigglesworth has stepped down as Chair of the Atlas Arteria Audit and Risk Committee. Current Independent Non-executive ATLAX Director Jean-Georges Malcor has been appointed Chair of the Audit and Risk Committee. The Boards have accelerated the previously announced process to identify a new Independent Chair of ATLAX, consistent with the requirements of the Director Representation Agreement with IFM. Both internal and external candidates will be considered.Board Change • May 21High number of new directorsCEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024.공고 • Apr 27IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion.IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion on April 27, 2026. A cash consideration valued at AUD 4.75 per share will be paid by IFM Global Infrastructure Fund and IFM Investors Pty Ltd. The Offer Price will be increased to the Maximum Consideration of AUD 5.10 per Security if Bidder's Relevant Interest in Atlas Arteria Securities is 45% or more prior to the close of the Offer. IFM GIF has access to existing cash balances, funding commitments from its investors and third party debt on an unconditional basis which in aggregate exceed the Offer Amount and are sufficient to support the Funding Commitments. Under the Funding Commitments, IFM GIF and IFM Finance will make available cash amounts in aggregate of not less than the Offer Amount for the purpose of funding the aggregate consideration for the acquisition of the Securities to which the Offer relates. The Funding Commitments are not subject to any conditions. Bidder may also proceed to compulsory acquisition of the Performance Rights which have not been exercised and that have not lapsed, or alternatively pursue other arrangements in relation to those Performance Rights. Atlas Arteria Limited advises that shareholders take no action in relation to the Offer. The transaction is subject to subject to antitrust regulations, approval by regulatory board / committee and third party approval needed. The Boards of Atlas Arteria will establish an Independent Board Committee to consider the Offer. Allens acted as legal advisor for IFM Investors Pty Ltd. Carey Olsen LLP acted as legal advisor for IFM Investors Pty Ltd. Jarden Australia Pty Limited acted as financial advisor for IFM Investors Pty Ltd. MUFG Corporate Markets Limited acted as transfer agent/registrar for IFM Investors Pty Ltd. Flagstaff Partners Pty Ltd and UBS AG act as financial advisor and Mallesons Stephen Jaques act as legal advisor for Atlas Arteria Limited.공고 • Mar 17Atlas Arteria Limited to Report First Half, 2026 Results on Aug 26, 2026Atlas Arteria Limited announced that they will report first half, 2026 results on Aug 26, 2026공고 • Mar 16Atlas Arteria Limited, Annual General Meeting, May 13, 2026Atlas Arteria Limited, Annual General Meeting, May 13, 2026.Board Change • Dec 30High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공고 • Nov 10Atlas Arteria Limited to Report Fiscal Year 2025 Results on Feb 26, 2026Atlas Arteria Limited announced that they will report fiscal year 2025 results on Feb 26, 2026공고 • Jul 18Atlas Arteria Limited Announces Virginia Supreme Court Decision Affirms SCC Rate Case AppealAtlas Arteria noted the decision made by the Supreme Court of Virginia (SCV) on 17 July 2025 affirming the 2024 State Corporation Commission's (SCC) decision denying Toll Road Investors Partnership II (TRIP II)'s latest toll rate application for the Dulles Greenway. TRIP II's pending federal case, which was stayed in anticipation of the SCV appeal decision, will now proceed. The federal complaint alleges constitutional violations distinct from those decided by the SCV and seeks compensatory, declarative, injunctive, and other relief, unavailable to TRIP II in the SCV appeal. TRIP II continues to engage with the SCC working group and anticipates submitting a new rate application this year.공고 • Mar 20Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2024, Payable on 4 April 2025Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2024, consistent with guidance provided in full year results announcement on 27 February 2025. Stapled securities trade ex-entitlement date is 25 March 2025. Record date is 26 March 2025. Estimated payment date is 4 April 2025.공고 • Mar 11Atlas Arteria Limited, Annual General Meeting, May 15, 2025Atlas Arteria Limited, Annual General Meeting, May 15, 2025.공고 • Feb 27+ 1 more updateAtlas Arteria Limited Reaffirms Distribution Guidance for Second Half of 2024Atlas Arteria Limited reaffirmed distribution guidance for second half of 2024. Atlas Arteria has reaffirmed distribution guidance of 20.0 cents per share for second half of 2024, in line with 2024 distribution guidance of 40.0 cents per share.Declared Dividend • Sep 22First half dividend of AU$0.20 announcedShareholders will receive a dividend of AU$0.20. Ex-date: 24th September 2024 Payment date: 7th October 2024 Dividend yield will be 11%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is not covered by earnings (194% earnings payout ratio) nor is it covered by cash flows (dividend approximately 6x free cash flows). The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 116% to bring the payout ratio under control. EPS is expected to grow by 68% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.공고 • Sep 19Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2024, consistent with guidance provided in half year results announcement on 29 August 2024. Stapled securities trade ex-entitlement: 24 September 2024. Record date: 25 September 2024. Estimated payment date: 7 October 2024. The distribution will be paid by Atlas Arteria International Limited (ATLIX) and Atlas Arteria Limited (ATLAX) and will be an unfranked distribution.Board Change • Sep 10High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Executive Director Danny Elia was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 30First half 2024 earnings released: EPS: AU$0.099 (vs AU$0.12 in 1H 2023)First half 2024 results: EPS: AU$0.099 (down from AU$0.12 in 1H 2023). Revenue: AU$69.6m (up 9.6% from 1H 2023). Net income: AU$144.3m (down 14% from 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Infrastructure industry in Europe. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.공고 • Aug 21+ 1 more updateAtlas Arteria Limited Appoints Hugh Wehby as Managing DirectorOn August 21, 2024, Atlas Arteria Limited announced that the Board has appointed Hugh Wehby as the company's new Managing Director. Hugh has extensive experience in the Australian listed infrastructure market, having held executive roles at Transurban and Sydney Airport. Hugh is currently Chief Commercial Officer at Transurban where his core focus is on delivering excellent on- road experience for customers, driving efficiency across all Australian markets and execution of corporate development opportunities. Previous to this role, Hugh was the Group Executive Partners, Delivery and Risk where he had global responsibility for strategic investment partnerships, major project delivery, new project opportunity development, risk, and health, safety, and environment. In North America, Hugh has been a member of Transurban's USA joint venture board since its inception, responsible for the delivery of a multi- billion dollar construction program and charged with identifying and developing growth opportunities. During his time at Transurban, he also drove the successful resolution of a complex dispute surrounding the West Gate Tunnel Project. Prior to Transurban, Hugh spent 10 years with Sydney Airport where he served in a number of roles including Chief Financial Officer and Chief Operating Officer. While COO, Hugh led the Company's initial response to the COVID-19 business disruption, refocused the organisation on safety and performance optimisation, and positioned the airport as a global sustainability leader in the infrastructure sector. Hugh's time in Macquarie Group and MAp Airports saw him based in Europe, where he primarily worked across the UK, Belgium, Denmark and Italy. His focus was on partnering with local senior management teams to drive strategic outcomes, financial growth and value.공고 • Jun 18+ 1 more updateAtlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025Atlas Arteria Limited announced that they will report first half, 2025 results on Aug 28, 2025Declared Dividend • Mar 24Final dividend of AU$0.20 announcedShareholders will receive a dividend of AU$0.20. Ex-date: 26th March 2024 Payment date: 8th April 2024 Dividend yield will be 10%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is not covered by earnings (132% earnings payout ratio) nor is it covered by cash flows (dividend approximately 6x free cash flows). The dividend has increased by an average of 20% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 47% to bring the payout ratio under control. EPS is expected to grow by 56% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.공고 • Mar 22+ 1 more updateAtlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing DirectorAtlas Arteria announced that CEO and Managing Director Graeme Bevans has notified the Boards of his intention to retire. Graeme has agreed that he will stay on until a new CEO and Managing Director has been appointed to ensure an orderly transition to new leadership, consistent with the 12 month notice period in Graeme's employment contract. Since his appointment as CEO and Managing Director in 2018, Graeme has built and led a highly skilled and capable team and instilled a strong, values-led culture across the Group. He has also led a number of major strategic initiatives to significantly unlock value in the portfolio and position the business for sustainable growth. These include restructuring the APRR holding with the buyout of Macquarie andMacquarie Fund investors and renegotiating shareholder arrangements to improve Atlas Arteria's governance arrangements; the restructuring of Warnow Tunnel; and the acquisition of Chicago Skyway. Together, these initiatives have diversified the Company's cash flows, extended average concession life; and positioned the business to take advantage of adjacent opportunities including the expected retendering of the APRR and AREA concessions as they mature in 2035 and 2036, respectively. A global search for Graeme's replacement will be undertaken, and in the interim Graeme will continue to be focussed on delivering the recently articulated strategy of business optimisation, associated growth opportunities and capital management.공고 • Mar 21Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2023, consistent with guidance provided in full year results announcement on 29 February 2024. Stapled securities trade ex-entitlement is on 26 March 2024. Record date is on 27 March 2024 and estimated payment date is on 8 April 2024.공고 • Mar 14Atlas Arteria Limited, Annual General Meeting, May 16, 2024Atlas Arteria Limited, Annual General Meeting, May 16, 2024, at 10:01 AUS Eastern Standard Time.Reported Earnings • Feb 29Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)Full year 2023 results: EPS: AU$0.22. Revenue: AU$134.0m (down 4.5% from FY 2022). Net income: AU$323.5m (up 21% from FY 2022). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Infrastructure industry in Europe.공고 • Oct 16Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive DirectorAtlas Arteria announced the appointment of Ms Laura Hendricks to the Board of Atlas Arteria Limited (ATLAX) as an Independent Non-executive Director effective immediately. Ms Hendricks is currently Chief Executive Officer of Transdev U.S., the largest operator and integrator of multiple modes of transportation in the United States. Laura has worked in a number of roles in the transportation industry across the US for more than 20 years and also has international experience working with shareholders in Europe, specifically in France and Germany. Ms Hendricks is also currently Chair of the North American Transit Alliance, an organization that advocates for the essential role that private contractors play in public transit. Prior to joining Transdev U.S., Ms Hendricks was President and/or CEO of several companies including Paint Drop by Valspar, Coach America and Merry Maids. Ms Hendricks also spent several years in executive leadership roles at Cintas and Fed Ex. Ms Hendricks is an accomplished senior executive with broad leadership experience in operations, including full P&L responsibility, business development, supply chain management, financial oversight, M&A, culture-building and change management. In her various roles, Ms Hendricks has also gained significant government relations experience in the United States, including working with public authorities and regulators. Ms Hendricks graduated from Xavier University with a Bachelor of Liberal Arts degree.공고 • Sep 22Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023Atlas Arteria announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2023. Stapled securities trade ex-entitlement is 25 September 2023, Record date is 26 September 2023 and Estimated payment date is 5 October 2023.공고 • Aug 31Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023Atlas Arteria Limited reaffirmed distribution guidance of 20.0 cents per security for first half of 2023, and 20.0 cents per security for second half of 2023.공고 • Jun 14Atlas Arteria Limited to Report Fiscal Year 2023 Results on Feb 29, 2024Atlas Arteria Limited announced that they will report fiscal year 2023 results on Feb 29, 2024공고 • Jun 07Atlas Arteria Limited Appoints Ken Daley as DirectorAtlas Arteria Limited appointed Ken Daley as Director. Date of appointment 30 May 2023.공고 • Jun 01Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023Atlas Arteria Limited announced that Ms Caroline Foulger will retire as a Director of Atlas Arteria International Limited with effect from 1 July 2023.공고 • Sep 19+ 1 more updateAtlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023Atlas Arteria Limited announced that they will report Q4, 2022 results on Feb 23, 2023이익 및 매출 성장 예측DB:M82 - 애널리스트 향후 추정치 및 과거 재무 데이터 (AUD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2028179552652217412/31/2027169514580186512/31/2026159470520241512/31/20251602608888N/A9/30/20251572799091N/A6/30/20251542999394N/A3/31/20251503179394N/A12/31/20241463369293N/A9/30/20241433189091N/A6/30/20241403008788N/A3/31/20241373128686N/A12/31/20231343248485N/A9/30/20231313158687N/A6/30/20231283078990N/A3/31/20231232878182N/A12/31/20221182677374N/A9/30/20221152646566N/A6/30/20221112605658N/A3/31/20221062225153N/A12/31/20211011834648N/A9/30/2021961343741N/A6/30/202191852935N/A3/31/202199132937N/A12/31/2020107-602939N/A9/30/2020128-374052N/A6/30/2020149-145264N/A3/31/202016225670N/A12/31/2019175176176N/A9/30/201916717N/A56N/A6/30/201915918N/A35N/A3/31/201914647N/A29N/A12/31/201813277N/A23N/A9/30/201812678N/A34N/A6/30/201812078N/A46N/A3/31/2018101270N/A32N/A12/31/201783462N/A18N/A9/30/201754506N/A-4N/A6/30/201725550N/A-25N/A3/31/201714388N/A-20N/A12/31/20163225N/A-16N/A9/30/20162162N/A-14N/A6/30/2016299N/A-13N/A3/31/2016292N/A-27N/A12/31/2015285N/A-42N/A9/30/2015371N/A-41N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: M82 의 연간 예상 수익 증가율(20.5%)이 saving rate(1.9%)보다 높습니다.수익 vs 시장: M82 의 연간 수익(20.5%)이 German 시장(15.9%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: M82 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: M82 의 수익(연간 4.8%)이 German 시장(연간 6.6%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: M82 의 수익(연간 4.8%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: M82의 자본 수익률은 3년 후 7%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YTransportation 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/23 20:37종가2026/07/23 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Atlas Arteria Limited는 16명의 분석가가 다루고 있습니다. 이 중 7명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Matthew RyanBarrenjoey Markets Pty LimitedShaurya VisenBofA Global ResearchRichard LeeBofA Global Research13명의 분석가 더 보기
공고 • Jul 08+ 1 more updateAtlas Arteria Limited Announces Board and Committee ChangesAtlas Arteria refers to the off-market takeover offer by Diamond Infraco 1 Pty Ltd. The IFM Takeover Offer closed on 7 July 2026. As previously announced, Debbie Goodin has retired as the Independent Non-executive Chair of Atlas Arteria Limited (ATLAX). This took effect a er the close of the IFM Takeover Offer on 7 July 2026. Current Independent Non-executive ATLAX Director John Wigglesworth has been appointed Interim Chair of ATLAX. As a result, Mr. Wigglesworth has stepped down as Chair of the Atlas Arteria Audit and Risk Committee. Current Independent Non-executive ATLAX Director Jean-Georges Malcor has been appointed Chair of the Audit and Risk Committee. The Boards have accelerated the previously announced process to identify a new Independent Chair of ATLAX, consistent with the requirements of the Director Representation Agreement with IFM. Both internal and external candidates will be considered.
Board Change • May 21High number of new directorsCEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024.
공고 • Apr 27IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion.IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion on April 27, 2026. A cash consideration valued at AUD 4.75 per share will be paid by IFM Global Infrastructure Fund and IFM Investors Pty Ltd. The Offer Price will be increased to the Maximum Consideration of AUD 5.10 per Security if Bidder's Relevant Interest in Atlas Arteria Securities is 45% or more prior to the close of the Offer. IFM GIF has access to existing cash balances, funding commitments from its investors and third party debt on an unconditional basis which in aggregate exceed the Offer Amount and are sufficient to support the Funding Commitments. Under the Funding Commitments, IFM GIF and IFM Finance will make available cash amounts in aggregate of not less than the Offer Amount for the purpose of funding the aggregate consideration for the acquisition of the Securities to which the Offer relates. The Funding Commitments are not subject to any conditions. Bidder may also proceed to compulsory acquisition of the Performance Rights which have not been exercised and that have not lapsed, or alternatively pursue other arrangements in relation to those Performance Rights. Atlas Arteria Limited advises that shareholders take no action in relation to the Offer. The transaction is subject to subject to antitrust regulations, approval by regulatory board / committee and third party approval needed. The Boards of Atlas Arteria will establish an Independent Board Committee to consider the Offer. Allens acted as legal advisor for IFM Investors Pty Ltd. Carey Olsen LLP acted as legal advisor for IFM Investors Pty Ltd. Jarden Australia Pty Limited acted as financial advisor for IFM Investors Pty Ltd. MUFG Corporate Markets Limited acted as transfer agent/registrar for IFM Investors Pty Ltd. Flagstaff Partners Pty Ltd and UBS AG act as financial advisor and Mallesons Stephen Jaques act as legal advisor for Atlas Arteria Limited.
공고 • Mar 17Atlas Arteria Limited to Report First Half, 2026 Results on Aug 26, 2026Atlas Arteria Limited announced that they will report first half, 2026 results on Aug 26, 2026
공고 • Mar 16Atlas Arteria Limited, Annual General Meeting, May 13, 2026Atlas Arteria Limited, Annual General Meeting, May 13, 2026.
Board Change • Dec 30High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. CEO, MD & Director Hugh Wehby was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공고 • Nov 10Atlas Arteria Limited to Report Fiscal Year 2025 Results on Feb 26, 2026Atlas Arteria Limited announced that they will report fiscal year 2025 results on Feb 26, 2026
공고 • Jul 18Atlas Arteria Limited Announces Virginia Supreme Court Decision Affirms SCC Rate Case AppealAtlas Arteria noted the decision made by the Supreme Court of Virginia (SCV) on 17 July 2025 affirming the 2024 State Corporation Commission's (SCC) decision denying Toll Road Investors Partnership II (TRIP II)'s latest toll rate application for the Dulles Greenway. TRIP II's pending federal case, which was stayed in anticipation of the SCV appeal decision, will now proceed. The federal complaint alleges constitutional violations distinct from those decided by the SCV and seeks compensatory, declarative, injunctive, and other relief, unavailable to TRIP II in the SCV appeal. TRIP II continues to engage with the SCC working group and anticipates submitting a new rate application this year.
공고 • Mar 20Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2024, Payable on 4 April 2025Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2024, consistent with guidance provided in full year results announcement on 27 February 2025. Stapled securities trade ex-entitlement date is 25 March 2025. Record date is 26 March 2025. Estimated payment date is 4 April 2025.
공고 • Mar 11Atlas Arteria Limited, Annual General Meeting, May 15, 2025Atlas Arteria Limited, Annual General Meeting, May 15, 2025.
공고 • Feb 27+ 1 more updateAtlas Arteria Limited Reaffirms Distribution Guidance for Second Half of 2024Atlas Arteria Limited reaffirmed distribution guidance for second half of 2024. Atlas Arteria has reaffirmed distribution guidance of 20.0 cents per share for second half of 2024, in line with 2024 distribution guidance of 40.0 cents per share.
Declared Dividend • Sep 22First half dividend of AU$0.20 announcedShareholders will receive a dividend of AU$0.20. Ex-date: 24th September 2024 Payment date: 7th October 2024 Dividend yield will be 11%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is not covered by earnings (194% earnings payout ratio) nor is it covered by cash flows (dividend approximately 6x free cash flows). The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 116% to bring the payout ratio under control. EPS is expected to grow by 68% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
공고 • Sep 19Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2024, consistent with guidance provided in half year results announcement on 29 August 2024. Stapled securities trade ex-entitlement: 24 September 2024. Record date: 25 September 2024. Estimated payment date: 7 October 2024. The distribution will be paid by Atlas Arteria International Limited (ATLIX) and Atlas Arteria Limited (ATLAX) and will be an unfranked distribution.
Board Change • Sep 10High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Executive Director Danny Elia was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 30First half 2024 earnings released: EPS: AU$0.099 (vs AU$0.12 in 1H 2023)First half 2024 results: EPS: AU$0.099 (down from AU$0.12 in 1H 2023). Revenue: AU$69.6m (up 9.6% from 1H 2023). Net income: AU$144.3m (down 14% from 1H 2023). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Infrastructure industry in Europe. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
공고 • Aug 21+ 1 more updateAtlas Arteria Limited Appoints Hugh Wehby as Managing DirectorOn August 21, 2024, Atlas Arteria Limited announced that the Board has appointed Hugh Wehby as the company's new Managing Director. Hugh has extensive experience in the Australian listed infrastructure market, having held executive roles at Transurban and Sydney Airport. Hugh is currently Chief Commercial Officer at Transurban where his core focus is on delivering excellent on- road experience for customers, driving efficiency across all Australian markets and execution of corporate development opportunities. Previous to this role, Hugh was the Group Executive Partners, Delivery and Risk where he had global responsibility for strategic investment partnerships, major project delivery, new project opportunity development, risk, and health, safety, and environment. In North America, Hugh has been a member of Transurban's USA joint venture board since its inception, responsible for the delivery of a multi- billion dollar construction program and charged with identifying and developing growth opportunities. During his time at Transurban, he also drove the successful resolution of a complex dispute surrounding the West Gate Tunnel Project. Prior to Transurban, Hugh spent 10 years with Sydney Airport where he served in a number of roles including Chief Financial Officer and Chief Operating Officer. While COO, Hugh led the Company's initial response to the COVID-19 business disruption, refocused the organisation on safety and performance optimisation, and positioned the airport as a global sustainability leader in the infrastructure sector. Hugh's time in Macquarie Group and MAp Airports saw him based in Europe, where he primarily worked across the UK, Belgium, Denmark and Italy. His focus was on partnering with local senior management teams to drive strategic outcomes, financial growth and value.
공고 • Jun 18+ 1 more updateAtlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025Atlas Arteria Limited announced that they will report first half, 2025 results on Aug 28, 2025
Declared Dividend • Mar 24Final dividend of AU$0.20 announcedShareholders will receive a dividend of AU$0.20. Ex-date: 26th March 2024 Payment date: 8th April 2024 Dividend yield will be 10%, which is higher than the industry average of 3.2%. Sustainability & Growth Dividend is not covered by earnings (132% earnings payout ratio) nor is it covered by cash flows (dividend approximately 6x free cash flows). The dividend has increased by an average of 20% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 47% to bring the payout ratio under control. EPS is expected to grow by 56% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
공고 • Mar 22+ 1 more updateAtlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing DirectorAtlas Arteria announced that CEO and Managing Director Graeme Bevans has notified the Boards of his intention to retire. Graeme has agreed that he will stay on until a new CEO and Managing Director has been appointed to ensure an orderly transition to new leadership, consistent with the 12 month notice period in Graeme's employment contract. Since his appointment as CEO and Managing Director in 2018, Graeme has built and led a highly skilled and capable team and instilled a strong, values-led culture across the Group. He has also led a number of major strategic initiatives to significantly unlock value in the portfolio and position the business for sustainable growth. These include restructuring the APRR holding with the buyout of Macquarie andMacquarie Fund investors and renegotiating shareholder arrangements to improve Atlas Arteria's governance arrangements; the restructuring of Warnow Tunnel; and the acquisition of Chicago Skyway. Together, these initiatives have diversified the Company's cash flows, extended average concession life; and positioned the business to take advantage of adjacent opportunities including the expected retendering of the APRR and AREA concessions as they mature in 2035 and 2036, respectively. A global search for Graeme's replacement will be undertaken, and in the interim Graeme will continue to be focussed on delivering the recently articulated strategy of business optimisation, associated growth opportunities and capital management.
공고 • Mar 21Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024Atlas Arteria Limited announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 31 December 2023, consistent with guidance provided in full year results announcement on 29 February 2024. Stapled securities trade ex-entitlement is on 26 March 2024. Record date is on 27 March 2024 and estimated payment date is on 8 April 2024.
공고 • Mar 14Atlas Arteria Limited, Annual General Meeting, May 16, 2024Atlas Arteria Limited, Annual General Meeting, May 16, 2024, at 10:01 AUS Eastern Standard Time.
Reported Earnings • Feb 29Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)Full year 2023 results: EPS: AU$0.22. Revenue: AU$134.0m (down 4.5% from FY 2022). Net income: AU$323.5m (up 21% from FY 2022). Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Infrastructure industry in Europe.
공고 • Oct 16Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive DirectorAtlas Arteria announced the appointment of Ms Laura Hendricks to the Board of Atlas Arteria Limited (ATLAX) as an Independent Non-executive Director effective immediately. Ms Hendricks is currently Chief Executive Officer of Transdev U.S., the largest operator and integrator of multiple modes of transportation in the United States. Laura has worked in a number of roles in the transportation industry across the US for more than 20 years and also has international experience working with shareholders in Europe, specifically in France and Germany. Ms Hendricks is also currently Chair of the North American Transit Alliance, an organization that advocates for the essential role that private contractors play in public transit. Prior to joining Transdev U.S., Ms Hendricks was President and/or CEO of several companies including Paint Drop by Valspar, Coach America and Merry Maids. Ms Hendricks also spent several years in executive leadership roles at Cintas and Fed Ex. Ms Hendricks is an accomplished senior executive with broad leadership experience in operations, including full P&L responsibility, business development, supply chain management, financial oversight, M&A, culture-building and change management. In her various roles, Ms Hendricks has also gained significant government relations experience in the United States, including working with public authorities and regulators. Ms Hendricks graduated from Xavier University with a Bachelor of Liberal Arts degree.
공고 • Sep 22Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023Atlas Arteria announced a distribution of 20.0 Australian cents per stapled security (cps) for the six months ended 30 June 2023. Stapled securities trade ex-entitlement is 25 September 2023, Record date is 26 September 2023 and Estimated payment date is 5 October 2023.
공고 • Aug 31Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023Atlas Arteria Limited reaffirmed distribution guidance of 20.0 cents per security for first half of 2023, and 20.0 cents per security for second half of 2023.
공고 • Jun 14Atlas Arteria Limited to Report Fiscal Year 2023 Results on Feb 29, 2024Atlas Arteria Limited announced that they will report fiscal year 2023 results on Feb 29, 2024
공고 • Jun 07Atlas Arteria Limited Appoints Ken Daley as DirectorAtlas Arteria Limited appointed Ken Daley as Director. Date of appointment 30 May 2023.
공고 • Jun 01Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023Atlas Arteria Limited announced that Ms Caroline Foulger will retire as a Director of Atlas Arteria International Limited with effect from 1 July 2023.
공고 • Sep 19+ 1 more updateAtlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023Atlas Arteria Limited announced that they will report Q4, 2022 results on Feb 23, 2023